癌症細胞的全球市場:癌症細胞類型，用途，終端用戶，各地區 - 規模，佔有率，預測，機會分析(2022年～2028年)

Cancer Cell Market, by Cancer Cell Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月15日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

本報告提供全球癌症細胞市場相關調查分析，提供市場概要，市場動態，趨勢，競爭情形，企業簡介等系統性資訊。

簡介
市場佔有率分析:各國(2022年·2028年)
與前一年同期比較成長分析:各國(2017～2028年)
北美
簡介
市場規模與預測:各癌症細胞類型(2017年～2028年)
市場規模與預測:各用途(2017年～2028年)
市場規模與預測:各終端用戶(2017年～2028年)
市場規模與預測:各國(2017年～2028年)
南美
簡介
市場規模與預測:各癌症細胞類型(2017年～2028年)
市場規模與預測:各用途(2017年～2028年)
市場規模與預測:各終端用戶(2017年～2028年)
市場規模與預測:各國(2017年～2028年)
歐洲
簡介
市場規模與預測:各癌症細胞類型(2017年～2028年)
市場規模與預測:各用途(2017年～2028年)
市場規模與預測:各終端用戶(2017年～2028年)
市場規模與預測:各國(2017年～2028年)
亞太地區
簡介
市場規模與預測:各癌症細胞類型(2017年～2028年)
市場規模與預測:各用途(2017年～2028年)
市場規模與預測:各終端用戶(2017年～2028年)
市場規模與預測:各國(2017年～2028年)
中東
簡介
市場規模與預測:各癌症細胞類型(2017年～2028年)
市場規模與預測:各用途(2017年～2028年)
市場規模與預測:各終端用戶(2017年～2028年)
市場規模與預測:各國(2017年～2028年)
非洲
簡介
市場規模與預測:各癌症細胞類型(2017年～2028年)
市場規模與預測:各用途(2017年～2028年)
市場規模與預測:各終端用戶(2017年～2028年)
市場規模與預測:各國各地區(2017年～2028年)

第9章競爭情形

企業簡介
- Abbott Laboratories
- Novartis International AG
- Arcellx
- Autolus Therapeutics
- Kite Pharma
- Cellectis
- Celyad Oncology
- Crescendo Biologics Limited
- GammaDelta Therapeutics Ltd.
- Bio-Rad Laboratories Inc
- QIAGEN Inc
- Thermo Fisher Scientific
- Merck Millipore
- Siemens Healthineers AG
- GE Healthcare

簡介目錄

Product Code: CMI4338

The global cancer cell market include various therapies used for the treatment of various cancers such as lung cancer, breast cancer, and others. There are various therapies for treatment of cancer such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy and others. The types of cancer such as carcinomas, sarcomas, leukemia, and others are caused due day to day lifestyles, and or more often, caused by carcinogens (cancer causing substances) such as tobacco etc.

Market Dynamics

Key players are focusing on research and development for treatment of cancers such as small cell lung cancer to strengthen their position in the global cancer cell market. For instance, in December 2019, Roche announced that the U.S. Food and Drug Administration (FDA) approved its Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane) for the initial (first-line) treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) with no epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) genomic tumor aberrations.

Key features of the study:

This report studies the current scenario as well as the future potential of the global cancer cell market. The market for cancer cell market is segmented on basis of cancer cell type, application, end user, and region.
This report provides in-depth analysis of the global cancer cell market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
It profiles leading players in the global cancer cell market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global cancer cell market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global cancer cell market

Detailed Segmentation:

Global Cancer Cell Market, By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
Global Cancer Cell Market, By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
Global Cancer Cell Market, By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
Global Cancer Cell Market, By Region:
- North America
  - By Cancer Cell Type:
  - Carcinomas
  - Sarcomas
  - Leukemia
  - Others
  - By Application:
  - Chemotherapy.
  - Radiation Therapy
  - Immunotherapy
  - Hormone Therapy
  - Targeted Drug Therapy
  - Others
  - By End User :
  - Hospitals & Clinics
  - Specialty Clinics
  - Diagnostic Laboratories
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Cancer Cell Type:
  - Carcinomas
  - Sarcomas
  - Leukemia
  - Others
  - By Application:
  - Chemotherapy.
  - Radiation Therapy
  - Immunotherapy
  - Hormone Therapy
  - Targeted Drug Therapy
  - Others
  - By End User :
  - Hospitals & Clinics
  - Specialty Clinics
  - Diagnostic Laboratories
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Cancer Cell Type:
  - Carcinomas
  - Sarcomas
  - Leukemia
  - Others
  - By Application:
  - Chemotherapy.
  - Radiation Therapy
  - Immunotherapy
  - Hormone Therapy
  - Targeted Drug Therapy
  - Others
  - By End User :
  - Hospitals & Clinics
  - Specialty Clinics
  - Diagnostic Laboratories
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Cancer Cell Type:
  - Carcinomas
  - Sarcomas
  - Leukemia
  - Others
  - By Application:
  - Chemotherapy.
  - Radiation Therapy
  - Immunotherapy
  - Hormone Therapy
  - Targeted Drug Therapy
  - Others
  - By End User :
  - Hospitals & Clinics
  - Specialty Clinics
  - Diagnostic Laboratories
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Cancer Cell Type:
  - Carcinomas
  - Sarcomas
  - Leukemia
  - Others
  - By Application:
  - Chemotherapy.
  - Radiation Therapy
  - Immunotherapy
  - Hormone Therapy
  - Targeted Drug Therapy
  - Others
  - By End User :
  - Hospitals & Clinics
  - Specialty Clinics
  - Diagnostic Laboratories
  - By Country/Region:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Cancer Cell Type:
  - Carcinomas
  - Sarcomas
  - Leukemia
  - Others
  - By Application:
  - Chemotherapy.
  - Radiation Therapy
  - Immunotherapy
  - Hormone Therapy
  - Targeted Drug Therapy
  - Others
  - By End User :
  - Hospitals & Clinics
  - Specialty Clinics
  - Diagnostic Laboratories
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Abbott Laboratories.*
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Novartis International AG
- Arcellx
- Autolus Therapeutics
- Kite Pharma
- Cellectis
- Celyad Oncology
- Crescendo Biologics Limited
- GammaDelta Therapeutics Ltd.
- Bio-Rad Laboratories Inc
- QIAGEN Inc
- Thermo Fisher Scientific
- Merck Millipore
- Siemens Healthineers AG
- GE Healthcare

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Cancer Cell Type
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunities
Impact Analysis
Key Developments
New Product Launches/Approvals
Merger-Acquisition Scenario
Regulatory Scenario
Pipeline Analysis
Epidemiology
PEST Analysis
Reimbursement

4. Global Cancer Cell Market - Impact of Coronavirus (COVID-19) Pandemic

Government Initiative To Combat Covid-19
COVID 19 Impact on Cancer Patients
COVID 19 Impact on Oncology Treatment

5. Global Cancer Cell Market, By Cancer Cell Type, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Carcinomas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Sarcomas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cancer Cell Market, By Application, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Chemotherapy.
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Targeted Drug Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Cancer Cell Market, By End User, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Cancer Cell Market, By Region, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, By Country, 2022 and 2028 (%)
Y-o-Y Growth Analysis, For Countries, 2017 - 2028
North America
Introduction
Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
Latin America
Introduction
Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa

9. Competitive Landscape

Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Arcellx
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Autolus Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Kite Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cellectis
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celyad Oncology
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Crescendo Biologics Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GammaDelta Therapeutics Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bio-Rad Laboratories Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- QIAGEN Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck Millipore
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siemens Healthineers AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies